The nocebo effect challenges the non-medical infliximab switch in practice.
Boone NW, Liu L, Romberg-Camps MJ, Duijsens L, Houwen C, van der Kuy PHM, Janknegt R, Peeters R, Landewé RBM, Winkens B, van Bodegraven AA.
Boone NW, et al. Among authors: landewe rbm.
Eur J Clin Pharmacol. 2018 May;74(5):655-661. doi: 10.1007/s00228-018-2418-4. Epub 2018 Jan 24.
Eur J Clin Pharmacol. 2018.
PMID: 29368188
Free PMC article.